Read + Share
Amedeo Smart
Independent Medical Education
Choi Y, Dharia NV, Jun T, Chang J, et al. Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors. Clin Cancer Res 2024;30:3788-3797.PMID: 38995268
Email
LinkedIn
Privacy Policy